tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Evans, 1 are a BUY (100%).
Analyst David Evans, currently employed at KEPLER CHEUVREUX, carries an average stock price target met ratio of 100% that have a potential upside of 31.55% achieved within 230 days.
David Evans’s has documented 2 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 07-Sep-2022.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 9/7/2022. The price target of $92.78 was fulfilled within 230 days with a profit of $22.25 (31.55%) receiving and performance score of 1.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1 months 12 days ago
9/9 (100%)
$4.91 (5.97%)
322
Buy
122.5
$1.61 (1.33%)
114.85
1 months 29 days ago
6/7 (85.71%)
$16.06 (15.09%)
401
Hold
114
$-6.89 (-5.70%)
7 months 8 days ago
14/14 (100%)
$10.23 (9.86%)
945
Sell
90.02
$-30.87 (-25.54%)
100.71
10 months 8 days ago
4/4 (100%)
$-1.19 (-1.30%)
161
Hold
78.13
$-42.76 (-35.37%)
85.24
10 months 11 days ago
2/3 (66.67%)
$-13.07 (-14.33%)
295
What Year was the first public recommendation made by David Evans?
